Señales en vivo de CEVI.ST | Maximiza tus Ganancias con Getagraph.com

Live Chart Being Loaded With Signals

Commentary (3 may 2024 @ 11:29):

Stats
Volumen de hoy	6 302.00
Volumen promedio	24 712.00
Capitalización de mercado	5.40B
EPS	SEK1.260 ( 2024-05-03 )
Próxima fecha de ganancias	( SEK1.730 ) 2024-07-18
Last Dividend	SEK0 ( N/A )
Next Dividend	SEK0 ( N/A )
P/E	38.26
ATR14	SEK0.747 (0.33%)

Volumen Correlación

Largo: 0.09 (neutral)

Corto: -0.97 (very strong negative)

Signal:(42.431) Neutral

CellaVision AB (publ) Correlación

10 Correlaciones Más Positivas

10 Correlaciones Más Negativas

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

CellaVision AB (publ) Correlación - Moneda/Commodity

0.41
( neutral )

0.52
( weak )

-0.40
( neutral )

-0.05
( neutral )

-0.60
( weak negative )

CellaVision AB (publ) Finanzas

Annual	2023
Ingresos:	SEK677.29M
Beneficio Bruto:	SEK463.04M (68.37 %)
EPS:	SEK5.46

FY	2023
Ingresos:	SEK677.29M
Beneficio Bruto:	SEK463.04M (68.37 %)
EPS:	SEK5.46

FY	2022
Ingresos:	SEK639.34M
Beneficio Bruto:	SEK438.32M (68.56 %)
EPS:	SEK4.96

FY	2021
Ingresos:	SEK565.55M
Beneficio Bruto:	SEK392.30M (69.37 %)
EPS:	SEK5.25

Financial Reports:

No articles found.

CellaVision AB (publ)

CellaVision AB (publ) develops and sells digital solutions for blood and body fluids analysis in health care services sector in Sweden, Europe, the Middle East, Africa, the Americas, and the Asia Pacific. The company provides CellaVision DM1200 and CellaVision DM9600, which automatically capture digital images of cells from blood smears and body fluid preparations; and CellaVision DC-1, an analyzer. It also offers CellaVision Peripheral Blood Application that enables laboratories to automate, standardize, and simplify morphological examination of peripheral blood smears; CellaVision Advanced RBC Application, which enables to perform comprehensive examination of red blood cell morphology; CellaVision Body Fluid Application that enables laboratories to automate, standardize, and simplify morphological examination of body fluid preparations; and CellaVision Remote Review Software, which removes restrictive geographical constraints from the smear review process. In addition, the company provides CellaVision Server Software that creates a single streamlined workflow within one or multiple testing sites; CellaVision Dashboard, a tool designed to give an at-a-glance view of CellaVision analyzer and reviewer metrics; CellaVision Proficiency Software, a cloud-based software designed to help laboratory managers assess, monitor, and promote staff competency in the area of cell morphology; CellaVision CellAtlas, which combines a series of mini lectures with an extensive cell image library; and CellaVision VET that offers digital solutions for medical microscopy in the field of hematology. It sells its products to hospital and commercial laboratories. CellaVision AB (publ) was incorporated in 1994 and is headquartered in Lund, Sweden.